



|                                                      | Low (N=157)  | Mild & High (N=56) | Total (N=213) | p value|
|:-----------------------------------------------------|:------------:|:------------------:|:-------------:|-------:|
|**Coverage of DTP1 (%)**                              |              |                    |               |   0.686|
|&nbsp;&nbsp;&nbsp;Median                              |    95.00     |       97.00        |     95.00     |        |
|&nbsp;&nbsp;&nbsp;Q1, Q3                              | 87.00, 99.00 |    87.50, 98.00    | 87.00, 98.00  |        |
|**Coverage of DTP3 (%)**                              |              |                    |               |   0.989|
|&nbsp;&nbsp;&nbsp;Median                              |    90.00     |       92.00        |     91.00     |        |
|&nbsp;&nbsp;&nbsp;Q1, Q3                              | 78.00, 97.00 |    84.25, 95.75    | 78.50, 97.00  |        |
|**General vaccine recommendation**                    |              |                    |               |        |
|&nbsp;&nbsp;&nbsp;1 dose                              |  1 (0.64%)   |     0 (0.00%)      |   1 (0.47%)   |        |
|&nbsp;&nbsp;&nbsp;2 doses                             |  0 (0.00%)   |     0 (0.00%)      |   0 (0.00%)   |        |
|&nbsp;&nbsp;&nbsp;3 doses                             | 44 (28.03%)  |    13 (23.21%)     |  57 (26.76%)  |        |
|&nbsp;&nbsp;&nbsp;4 doses                             | 44 (28.03%)  |    12 (21.43%)     |  56 (26.29%)  |        |
|&nbsp;&nbsp;&nbsp;5 doses                             | 44 (28.03%)  |    18 (32.14%)     |  62 (29.11%)  |        |
|&nbsp;&nbsp;&nbsp;6 doses                             | 24 (15.29%)  |    13 (23.21%)     |  37 (17.37%)  |        |
|**General vaccine recommendation for toddlers, -3yr** |              |                    |               |        |
|&nbsp;&nbsp;&nbsp;1 dose                              |  1 (0.64%)   |     0 (0.00%)      |   1 (0.47%)   |        |
|&nbsp;&nbsp;&nbsp;2 doses                             |  0 (0.00%)   |     0 (0.00%)      |   0 (0.00%)   |        |
|&nbsp;&nbsp;&nbsp;3 doses                             | 62 (39.49%)  |    32 (57.14%)     |  94 (44.13%)  |        |
|&nbsp;&nbsp;&nbsp;4 doses                             | 93 (59.24%)  |    24 (42.86%)     | 117 (54.93%)  |        |
|&nbsp;&nbsp;&nbsp;5 doses                             |  1 (0.64%)   |     0 (0.00%)      |   1 (0.47%)   |        |
|&nbsp;&nbsp;&nbsp;6 doses                             |  0 (0.00%)   |     0 (0.00%)      |   0 (0.00%)   |        |
|**General vaccine recommendation for children, 3+yr** |              |                    |               |   0.002|
|&nbsp;&nbsp;&nbsp;Not provided                        | 79 (50.32%)  |    19 (33.93%)     |  98 (46.01%)  |        |
|&nbsp;&nbsp;&nbsp;1 dose                              | 47 (29.94%)  |    12 (21.43%)     |  59 (27.70%)  |        |
|&nbsp;&nbsp;&nbsp;2 doses                             | 31 (19.75%)  |    24 (42.86%)     |  55 (25.82%)  |        |
|&nbsp;&nbsp;&nbsp;3 doses                             |  0 (0.00%)   |     1 (1.79%)      |   1 (0.47%)   |        |
|**Vaccine recommendation for pregnant**               |              |                    |               |   0.088|
|&nbsp;&nbsp;&nbsp;No                                  | 129 (82.17%) |    40 (71.43%)     | 169 (79.34%)  |        |
|&nbsp;&nbsp;&nbsp;Yes                                 | 28 (17.83%)  |    16 (28.57%)     |  44 (20.66%)  |        |
|**Vaccine recommendation for adults**                 |              |                    |               |   0.005|
|&nbsp;&nbsp;&nbsp;No                                  | 150 (95.54%) |    47 (83.93%)     | 197 (92.49%)  |        |
|&nbsp;&nbsp;&nbsp;Yes                                 |  7 (4.46%)   |     9 (16.07%)     |  16 (7.51%)   |        |
|**Vaccine recommendation for risk groups**            |              |                    |               |   0.450|
|&nbsp;&nbsp;&nbsp;No                                  | 138 (87.90%) |    47 (83.93%)     | 185 (86.85%)  |        |
|&nbsp;&nbsp;&nbsp;Yes                                 | 19 (12.10%)  |     9 (16.07%)     |  28 (13.15%)  |        |
|**Vaccine type**                                      |              |                    |               |   0.001|
|&nbsp;&nbsp;&nbsp;wP                                  | 101 (64.33%) |    22 (39.29%)     | 123 (57.75%)  |        |
|&nbsp;&nbsp;&nbsp;aP                                  | 44 (28.03%)  |    31 (55.36%)     |  75 (35.21%)  |        |
|&nbsp;&nbsp;&nbsp;Both                                |  12 (7.64%)  |     3 (5.36%)      |  15 (7.04%)   |        |
|**Pertussis status in 2022/2023**                     |              |                    |               |   0.457|
|&nbsp;&nbsp;&nbsp;Low                                 | 49 (31.21%)  |    21 (37.50%)     |  70 (32.86%)  |        |
|&nbsp;&nbsp;&nbsp;Normal                              |  13 (8.28%)  |     4 (7.14%)      |  17 (7.98%)   |        |
|&nbsp;&nbsp;&nbsp;High                                |  7 (4.46%)   |     1 (1.79%)      |   8 (3.76%)   |        |
|&nbsp;&nbsp;&nbsp;Resurgence                          | 16 (10.19%)  |     2 (3.57%)      |  18 (8.45%)   |        |
|&nbsp;&nbsp;&nbsp;Unavailable                         | 72 (45.86%)  |    28 (50.00%)     | 100 (46.95%)  |        |
